Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDevdatt Kurdikar - President, CEO ...
Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...
Insomnia is not a listed side effect of Zepbound from clinical trials. Fatigue was more commonly reported. While not a typical side effect, sleep disturbances could arise indirectly from Zepbound’s ...
It’s tough to avoid the current hype about the health benefits of injecting peptides. Although these substances – essentially ...
The FDA has proposed excluding weight-loss drugs, such as Ozempic/Wegovy and Zepbound from a key compounding list, ...
On April 30, 2026, the U.S. Food and Drug Administration (FDA) announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List (“503B Bulks ...
Your iPhone or Android phone can work overtime as a full-on gaming console with the help of these mobile controllers.
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Lilly is trying to tackle a fundamental issue with the GLP-1 medicines that have transformed obesity treatment. Patients are losing a lot of weight but have little interest in taking injections for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results